UNSPSC 51363101: Alonimid

This classification denotes a sedative and hypnotic with the molecular formula C14H13NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 14144823D4, chemically known as 1,2,3,4-tetrahydronaphthalin-1-spiro-3-piperidin-4,2,6-dion but generally known as alonimid, which bears US NIH Compound Identifier 17928. European Medicines Agency schedules Alonimid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05356MIG.

UNSPSC 51363101 Alonimid is a Commodity code under which state and local governments procure pharmaceutical and over-the-counter products, including naloxone, safe drug deactivation systems, generic multi-source pharmaceuticals, and OTC medications for community health, emergency response, and employee benefit programs. The scope encompasses both direct procurement of finished pharmaceuticals and the establishment of master supply agreements with manufacturers to serve multiple state and local jurisdictions through authorized wholesalers. Issuing bodies include county health departments, state health and human services agencies, and multistate cooperative purchasing alliances. Seminole County, Florida and the Texas Health and Human Services Commission represent active buyers in this space, with cooperative purchasing vehicles such as the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) aggregating demand across multiple jurisdictions including state and local participants.

Recent activity spans Florida, Texas, and Minnesota-anchored multistate agreements. Seminole County posted IFB 60459723LAS on June 30, 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, response deadline July 26, 2023. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026 to explore direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements, framing a future formal RFP. MMCAP, administered by the Minnesota Department of Administration, posted RFP S1070000015802 on January 20, 2026 seeking generic pharmaceuticals and OTC products through three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, Morris & Dickson), with proposals due March 26, 2026 and contract effectiveness July 1, 2026; evaluation weights 75 percent on price competitiveness, 10 percent on fixed pricing, and 5 percent each on format compliance, EDI capability, and administrative fee agreement. Vendors must hold cGMP and Drug Supply Chain Security Act certifications and carry commercial general liability insurance of $5,000,000 per occurrence.